The eukaryotic initiation factor 3f (eIF3f) is the p47 subunit of the multi-subunit eIF3 complex. eIF3 plays an important role in translation initiation. In the present study, we investigate the biological function of eIF3f in translation and apoptosis in tumor cells. We demonstrated for the first time that eIF3f is downregulated in most human tumors using a cancer profiling array and confirmed by real-time reverse transcription PCR in melanoma and pancreatic cancer. Overexpression of eIF3f inhibits cell proliferation and induces apoptosis in melanoma and pancreatic cancer cells. Silencing of eIF3f protects melanoma cells from apoptosis. We further investigated the biological function of eIF3f. In vitro translation studies indicate that eIF3f is a negative regulator of translation and that the region between amino acids 170 and 248 of eIF3f is required for its translation regulatory function. Ectopic expression of eIF3f inhibits translation and overall cellular protein synthesis. Ribosome profile and ribosomal RNA (rRNA) fragmentation assays revealed that eIF3f reduces ribosomes, which may be associated with rRNA degradation. We propose that eIF3f may play a role in ribosome degradation during apoptosis. These data provide critical insights into the cellular function of eIF3f and in linking translation initiation and apoptosis.
Introduction
Translation initiation in eukaryotes is a rate-limiting step in protein synthesis. It is a complicated process that involves many eukaryotic initiation factors (eIFs). Translation initiation in eukaryotes requires the association of a ternary complex (TC) intermediate composed of the eukaryotic initiation factor 2 (eIF2), GTP and Met-tRNAi with the 40S ribosome to form a 43S preinitiation complex. The binding of the TC to 40S ribosomes is promoted by three additional initiation factors, eIF3, eIF1 and eIF1A (Majumdar et al., 2003) . eIF3 prevents premature association of the 40S and 60S ribosomal subunits. eIF3 also links the 40S ribosome to the mRNA by binding to eIF4F complex to generate the 48S pre-initiation complex. Thus, eIF3 plays an important role in translation initiation. Mammalian eIF3 is the largest of the initiation factors and exists as a protein complex with at least 12 non-identical subunits (Sonenberg et al., 2000) . However, the functions of the individual subunits have not yet been fully defined in mammals.
eIF3j has been reported to be required for the stable binding of eIF3 and its subcomplexes to 40S ribosomal subunits in vitro (Fraser et al., 2004) . A simpler complex of five subunits was isolated from the budding yeast Saccharomyces cerevisiae, and was found to restore Met-tRNAi binding to 40S ribosomes in lysates from a mutant strain defective in eIF3 (Phan et al., 1998) . The five eIF3 subunits in this active yeast complex are homologous to the mammalian subunits eIF3a, eIF3b, eIF3c, eIF3g and eIF3i (Phan et al., 1998) . However, yeast cells do not contain homologues of the other mammalian eIF3 subunits (eIF3d, e, f, h, k), with the exception of eIF3j. It is noteworthy that four of the subunits lacking in yeast (eIF3d, e, f, h) are conserved in Caenorhabditis elegans, Drosophila melanogaster, plants and the fission yeast Schizosaccharomyces pombe (Asano et al., 1997) . These facts suggest that mammalian eIF3 may consist of an active core of five subunits (eIF3a, b, c, g, i) , with the remaining subunits serving to modulate eIF3 activity. One example is Int-6, the eIF3e non-core subunit of eIF3. Akiyoshi et al. (2001) reported that eIF3e in fission yeast associates with 40S ribosomes and co-purifies with eIF3, yet deletion of its gene generates a viable strain with a slow-growth phenotype. This suggests that eIF3e is not an essential subunit of eIF3 but might be involved in the regulation of eIF3 activity for translation of specific mRNAs in fission yeast.
eIF3f is a member of the Mov34 family, which is involved in translation initiation, regulation of the proteasome and transcription (Aravind and Ponting, 1998) . We used a yeast two-hybrid screening strategy and identified eIF3f as an interacting partner of caspase processed C-terminal kinase domain of the cyclindependent kinase 11 (CDK11 p46 ) protein kinase (Shi et al., 2003) . CDK11 is a family member of cyclindependent kinases, which appears to be an important downstream effector in apoptotic signaling (Tang et al., 1998; Ariza et al., 1999) . Caspase cleavage of CDK11 p110 leads to the activation of the CDK11 p46 isoform during apoptosis (Shi et al., 1994; Beyaert et al., 1997) . We demonstrated that eIF3f can interact with CDK11 p46 in vitro and in vivo, and the interaction can be strengthened by stimulation of apoptosis in melanoma cells. eIF3f appears to interact with CDK11 p46 through the Mov34/ JAB motif. In the present study, we demonstrated for the first time that eIF3f is downregulated in several human tumors and that eIF3f appears to be a negative regulator of translation and cell growth and plays a role in apoptotic signaling.
Results

eIF3f is downregulated in several human tumors
To evaluate eIF3f expression in different human tumor samples, the eIF3f cDNA was used as a probe on a cancer profiling array containing normalized 154 cDNA pairs from tumor and corresponding normal tissues of individual patients, enabling the study of eIF3f expression in normal and tumor samples side by side. The ratio of the signal intensity of each pair of tumor and normal and the statistic analysis of each tumor type are listed in Table 1 . Surprisingly, eIF3f transcript levels showed a substantial decrease in several of the tested tumors relative to matched normal tissues (Figure 1a , upper panel and Table 1 ). In particular, 100% of pancreas and vulva tumors, 90% of breast tumors and 70% of ovary and small intestine tumors present on the array showed a significant decrease of eIF3f expression ( Figure 1b and Table 1 ). In skin tumors, there are seven patients who were diagnosed with melanoma and three non-melanoma skin cancers. With regard to the melanomas, 71% of the specimens have a decreased eIF3f expression. However, because of the limitation of the number of specimens, it is not statistically significant (Table 1) . Also note that G361, a melanoma cell line, is greatly downregulated for eIF3f ( Figure 1a ). Ubiquitin probe was used as a control ( Figure 1a , lower panel).
To confirm that the mRNA level of eIF3f is decreased in melanoma, we performed quantitative real-time reverse transcription-PCR (RT-PCR) with five melanoma cell lines UACC612, UACC827, UACC647, UACC1227 and A375 compared with normal primary melanocytes and fibroblasts and four additional melanoma specimens 4M, 6M, 8M and 1002 compared with (Philip et al., 1995; Miura et al., 2002) . Consistent with our cancer profiling array results, eIF3f mRNA was significantly decreased in the melanoma cell lines and specimens tested compared to primary melanocytes and fibroblasts or normal skin (Figure 2a) . We also used the same approach to confirm the decrease of eIF3f expression in pancreatic cancer. Three pancreatic cancer cell lines BxPc3, MiaPaCa and Hs766T and four additional pancreatic cancer specimens 0023T, 0035T, 161 and 191 showed significantly reduced eIF3f expression relative to normal pancreatic tissue or a nonmalignant pancreatic tissue 151 (Figure 2b ).
eIF3f inhibits melanoma cell growth and induces apoptosis
To investigate the effect of eIF3f on tumor cells, we transfected pcDNA3-eIF3f or empty vector pcDNA3 into A375 melanoma cell line and monitored its effect on tumor cell growth, colony formation and apoptosis induction compared to control vector-transfected cells. Two eIF3f-overexpressing A375 clones grew significantly slower than vector-transfected cells (Figure 3a) . We further compared the ability of these cell lines to form colonies. Consistent with our cell growth rate data, eIF3f-overexpressing cells form significantly fewer colonies than vector-transfected cells (Figure 3b ). The overexpression of eIF3f was confirmed by immunoblot with eIF3f antibody (Figure 3b ). We then investigated whether the inhibition of cell growth by eIF3f associates with increased apoptosis using acridine orange and ethidium bromide staining and fluorescent microscopy. We saw significantly increased apoptosis in cells transfected with eIF3f compared to those transfected with the vector alone ( Figure 3c ). The increased apoptosis in eIF3f-transfected melanoma cells was also confirmed by 7-aminoactinomycin D (7-AAD) staining and flow cytometry ( Figure 3d ). Our results indicated that overexpression of eIF3f induces apoptosis in melanoma cells.
eIF3f inhibits cell proliferation and induces apoptosis in pancreatic cancer cells To investigate if eIF3f has the same effect on cell proliferation and apoptosis in pancreatic cancer cells, we transiently transfected pcDNA3-eIF3f or empty vector pcDNA3 into BxPc3 pancreatic cancer cell line and monitored its effect on cell proliferation and apoptosis using MTT assay and acridine orange/ethidium bromide staining and fluorescent microscopy. eIF3f-overexpressing cells have significantly decreased cell proliferation and increased apoptosis compared to those transfected with the vector alone ( Figure 4 ). The overexpression of eIF3f in BxPc3 cells was confirmed by Western blot (Figure 4b ). Our results indicated that eIF3f also inhibits cell proliferation and induces apoptosis in pancreatic cancer cells. 
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To determine if eIF3f-induced apoptosis is caspase 3 dependent or whether alteration occurs in Bcl-2, Bax or Bcl-XL , A375 cells were transfected with pcDNA3 or pcDNA3-eIF3f. Caspase 3/7 activity was measured using the Caspase-Glot 3/7 Assay kit (Promega, Madison, WI, USA). There is no difference of caspase 3/7 activity between vector-and eIF3f-transfected cells (data not shown). Western blot analysis using caspase 3 antibody also confirmed that there is no caspase 3 activation after eIF3f transfection (data not shown). Subcellular fractionation or whole cell lysate and Western blot analysis in vector-or eIF3f-transfected A375 cells show no change in Bcl-2, Bax and Bcl-XL (data not shown). eIF3f also does not induce cytochrome c release as indicated by mitochondria fractionation and Western blot analysis (data not shown). These data suggest that eIF3f-induced apoptosis is caspase 3/7 and Bcl-2, Bax or Bcl-XL independent. Furthermore, overexpression of eIF3f does not induce eIF2a phosphorylation (data not shown).
Knockdown of endogenous eIF3f by siRNA attenuates apoptosis in A375 cells
We next examined the role of endogenous eIF3f on apoptosis in A375 cells. Pre-designed eIF3f siRNA or scrambled siRNA (Ambion Inc., Austin, TX, USA) was transfected into A375 cells. Endogenous eIF3f protein levels were efficiently and specifically reduced especially at 72 h after transfection as determined by Western blot analysis (Figure 5a ). To examine the effect of eIF3f on apoptosis, we incubated control and eIF3f knockdown A375 cells with staurosporine (10 ng/ml). After 36 h, apoptosis was measured and quantified. As shown in Figure 5b , cells with reduced eIF3f expression were protected from the effects of staurosporine treatment. Control cells with normal levels of eIF3f underwent apoptosis.
eIF3f is a negative regulator of translation in vitro As eIF3f is a subunit of eIF3 complex, which is involved in translation initiation, we further investigated whether the apoptosis induced by eIF3f is related to translation. We first used the rabbit reticulocyte translation system to investigate the function of eIF3f in translation in vitro. In this system, firefly luciferase mRNA is translated into protein and either luciferase activity is measured quantitatively with a luminometer or luciferase protein produced is assessed by incorporated [ 35 S]methionine and autoradiography (Shi et al., 2003) . Previously, we established that our assay conditions are within the linear range by conducting time-course experiments and titration experiments with various amounts of luciferase mRNA (Shi et al., 2003) . Luciferase mRNA (40 ng) was translated in the presence of buffer or increasing concentrations of glutathione S-transferase (GST) control or recombinant eIF3f protein. A significant dosedependent inhibition of luciferase synthesis was observed in the eIF3f group, but not in the GST control group (Figure 6a ). Full-length luciferase protein was produced as assayed by SDS-polyacrylamide gel electrophoresis (PAGE) analysis. To examine which region of eIF3f is involved in translation inhibition in vitro, equal amounts of either GST or recombinant wild-type eIF3f or four truncated forms of eIF3f were tested. The inhibition of translation was seen only with the wild-type eIF3f or the two truncated forms of eIF3f (eIF3f-1 and eIF3f-2) (Figure 6b ). All three peptides could directly bind to CDK11 p46 and contain either the complete Mov34 domain or the C-terminal part of Mov34 domain (Figure 6b ) (Shi et al., 2003) . Neither the N-terminal portion (eIF3f-4, residues 1-113) nor the C-terminal portion (eIF3f-3, residues 248-360) could bind to CDK11 p46 or inhibit luciferase synthesis. These data suggest that the region between amino acids 170 and 248 of eIF3f is required for the translation inhibition function of eIF3f.
As the addition of unfolded, recombinant proteins to the translation system may lead to the activation of eIF2a phosphorylation and a non-specific inhibition of translation, we further examined the phosphorylation level of eIF2a in different reactions by Western blotting with phospho-eIF2a antibody. The result showed equal phosphorylation level of eIF2a compared to buffer when different recombinant proteins were added to the translation system (Figure 6c ). These data show that inhibition of translation by eIF3f and its deletion mutant is specific.
eIF3f inhibits translation in mammalian cells
To examine whether eIF3f inhibits translation in vivo, a luciferase reporter plasmid was transfected into A375 cells transfected with either pcDNA3 or pcDNA3-eIF3f. Luciferase activity was then measured 24 h after transfection. Consistent with our cell-free data, luciferase synthesis was significantly inhibited in A375 cells that overexpress eIF3f (Figure 7a ). To confirm that eIF3f affects translation, not transcription, real-time RT-PCR was performed to quantify the luciferase mRNA. The threshold cycle (C t ) for luciferase mRNA was normalized against GAPDH mRNA. No difference of luciferase mRNA was observed among A375 cells carrying pcDNA3 or eIF3f (Figure 7b) . The results indicated that eIF3f inhibits protein synthesis in mammalian cells at the translational level and not by affecting mRNA levels.
eIF3f inhibits overall protein synthesis in vivo To further investigate the impact of eIF3f on overall cellular protein synthesis, we used A375 cells transfected with pcDNA3 or pcDNA3-eIF3f. Overall protein synthesis, as measured by pulse-labeling cells with [ 3 H] leucine in vivo, was significantly lower in eIF3f overexpressing cells compared to vector-transfected cells (Figure 8 ). Thus, eIF3f can also inhibit the overall rate of cellular protein synthesis, which is consistent with our in vitro and reporter system translation inhibition data (Figures 6 and 7) .
Overexpression of eIF3f reduces ribosomes
We then investigated the mechanism of the translation inhibition function of eIF3f using sucrose density gradient centrifugation. The ribosome profile was monitored by the A 254 scan as described in Materials and methods. We first examined the ribosome binding of endogenous eIF3f in relation to eIF3. A375 cells transiently transfected with pCMV-HA empty vector were analysed by sucrose gradient centrifugation, SDS/ PAGE and immunoblotting with eIF3b and eIF3f antibodies. eIF3, as identified by eIF3b antibody, was found mostly associated with 40S ribosomal subunits ( Figure 9) . Most of the endogenous eIF3f colocalizes with eIF3b in the 40S region of the gradient, indicating under normal condition, endogenous eIF3f is bound to 40S ribosomal subunit. In A375 cells transiently transfected with pCMV-HA-eIF3f, some of the hemagglutinin (HA)-tagged exogenous eIF3f is found bound to 40S ribosomal subunit, with many HA-tagged eIF3f found at the top of the gradient, as expected for an overproduced subunit of eIF3 (Figure 9b, lower panel) . Most of the endogenous eIF3b remains bound to 40S ribosomal subunit. However, in cells overexpressing eIF3f, significant decreased ribosomes (especially 60S and 80S ribosomes) were observed (Figure 9a ). The 60S/ 40S ribosomal subunit ratio decreased by about 50% (from 3.06 to 1.46). It is also noteworthy that there was Aberrant expression of eIF3f in tumor cells J Shi et al an increase in the RNA absorbance at the top of the gradient, which suggests an increased amount of rRNA degradation. Next, we investigated the ribosome profile of cells undergoing apoptosis. We performed the same experiments on Jurkat T cells and A375 melanoma cells that were either untreated or treated with anti-Fas or staurosporine to trigger apoptosis. Interestingly, a decrease of 60S ribosomal subunit (60S/40S ribosomal subunit ratio also decreased by about 50% in both cases) and an increase of the absorbance at the top of the gradient were also observed in cells undergoing apoptosis (Figures 10a and 11a) . There was no alteration in the distribution of eIF3b and eIF3f in the fractions (Figures 10b and 11b) . These results suggest that the reduced 60S ribosomal subunit observed in eIF3f-transfected cells may contribute to apoptosis or may be a result of apoptosis.
eIF3f induces rRNA degradation
The marked decrease in ribosomes in eIF3f-transfected cells cannot be explained by the increased dissociation of 40S and 60S ribosomal subunits, because 40S and 60S ribosomal subunits did not increase. As we also Figure 6 eIF3f inhibits translation in a dose-dependent manner in vitro. Luciferase mRNA was translated in an in vitro translation system in the presence of (a) buffer, glutathione S-transferase (GST) or eIF3f; (b) GST, eIF3f or the four deletion mutants of eIF3f. Luciferase protein synthesis was analysed by gel electrophoresis followed by autoradiography. Synthesized luciferase activity was also measured with a luminometer. *Po0.05; **Po0.01; ***Po0.001. (c) The same in vitro translation assay was performed as described above. Five microliters of reactions were separated by SDS-polyacrylamide gel electrophoresis followed by immunoblot with phosphor-eIF2a antibody and a-tubulin antibody as control.
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observed an increase of RNA absorbance at the top of the gradient in eIF3f-transfected cells, we suspected that eIF3f may play a role in ribosome degradation, which contributes to apoptotic process. To examine whether eIF3f plays a role in the rRNA degradation, A375 cells were transiently transfected with pCMV-HA control vector or HA-tagged eIF3f. Total RNA was isolated and analysed by Northern blot analysis using probes complementary to 28S and 18S rRNA. rRNA degradation was observed in the eIF3f-transfected cells (Figure 12a ). No alteration of rRNA was detected in vector control samples. Our results also indicate that 28S rRNA is the major rRNA that is degraded in eIF3f-transfected cells as well as anti-Fas-treated Jurkat T cells and staurosporine-treated A375 cells ( Figure  12a ). Minor degradation of 18S rRNA is observed in eIF3f-transfected cells as well as anti-Fas-treated Jurkat T cells. These data suggest that the decreased 60S ribosomal subunit demonstrated in the ribosomal profile studies may be due to rRNA degradation (Figures 9-11 ).
To rule out the possibility that the rRNA degradation is due to preparation problems, a time-course study was performed. Jurkat T cells were treated with anti-Fas (100 ng/ml) for 0, 1, 2, 4, 6 and 8 h and A375 cells were treated with staurosporine (10 ng/ml) for 0, 24, 36, 48 and 72 h. Cells were harvested and total RNA was Figure 8 Ectopic expression of eIF3f inhibits overall cellular protein synthesis in A375 cells. Overall protein synthesis in A375 cells transfected with pcDNA3 or pcDNA3-eIF3f was measured by pulse-labeling cells with [ isolated and analysed by Northern blot analysis as described above. The 28S rRNA degradation was seen after 1 h of anti-Fas treatment and gradually increased over time in Jurkat T cells (Figure 12b) . In A375 cells, the 28S rRNA degradation was seen at 24 and 36 h after treatment, and then diminished after 48 h of treatment (Figure 12b ). The degradation of 18S rRNA can be seen in treated Jurkat T cells and A375 cells, but is not as significant as 28S rRNA degradation (Figure 12b ). This result indicated that the rRNA degradation that was seen in Figure 12a is not due to sample preparation problems.
Discussion
The rate of synthesis of any given protein is determined primarily by the level of translation initiation (Pestova et al., 2001) . Altering the expression level or the function of eIF3 may influence the synthesis of some proteins and consequently cause abnormal cell growth and malignant transformation. eIF3 comprises at least 12 non-identical subunits of which six have been implicated in human cancers (eIF3a, b, c, h, i and e) (Joseph et al., 2002; Watkins and Norbury, 2002) . eIF3f is another eIF3 subunit whose function is not known. In the present study, we demonstrated that the expression of eIF3f is downregulated in several human tumors, including melanoma and pancreatic cancer (Figure 1 ). This decreased expression of eIF3f is further confirmed in melanoma and pancreatic cancer by real-time RT-PCR (Figure 2) . Furthermore, we demonstrated that overexpression of eIF3f inhibits tumor cell proliferation and induces apoptosis in melanoma and pancreatic cancer cells (Figures 3 and 4) . Knockdown of endogenous eIF3f inhibits apoptosis in melanoma cells ( Figure 5 ). The eIF3f gene is located at human chromosome band 11p15.4. Chromosomal abnormalities at 11p15 have been seen in leukemia, malignant melanoma, lung, ovary, pancreas, kidney and breast adenocarcinomas (The Recurrent Chromosome Aberrations in Cancer 2003 Database, NCBI). Based on our data that eIF3f inhibits cell growth and induces apoptosis in two tumor types, eIF3f may be a negative regulator of tumor cell growth.
To investigate the biological function of eIF3f, we designed experiments to explore the role of eIF3f in translation both in vitro and in vivo. All of our data suggest that eIF3f is a negative regulator of translation. The 60S ribosomal subunit decreases during apoptosis in Jurkat T cells. (a) Jurkat T cells were treated with anti-Fas (100 ng/ml) for 6 h followed by polysome profile analysis as described in Figure 9 . (b) The proteins in the fractions were analysed by 10% SDS/polyacrylamide gel electrophoresis and Western blot with eIF3f and eIF3b antibodies.
Aberrant expression of eIF3f in tumor cells J Shi et al A significant inhibition of overall protein synthesis has been observed in various cell types when cells are committed to apoptosis (Wallach, 1997; Clemens et al., 1998; Morley et al., 1998) . This downregulation of protein synthesis may either activate apoptosis or protect cells against noxious agents and ensure the conservation of resources needed for survival (Sheikh and Fornace, 1999) . We demonstrated using polysome profile and Northern blot analysis that ectopic expression of eIF3f is associated with reduced 60S ribosomal subunit and degradation of 28S rRNA. We postulate that eIF3f may be a negative regulator of translation and loss of eIF3f contributes to apoptosis in tumor cells by deregulating translation. (Guo et al. 2000) reported that the IFN-induced cellular protein P56 interacts with eIF3e and represses translation . However, no direct evidence has been shown that eIF3e can inhibit translation. Our present study shows for the first time in human cells that a noncore eIF3 subunit, eIF3f, negatively regulates translation. In the present study, we observed a suppression of protein synthesis as well as a reduction in ribosomal subunits (especially 60S ribosomal subunit) and an increase of rRNA degradation (especially 28S rRNA) in eIF3f-transfected cells compared to vector-transfected cells. There is precedent in the literature suggesting a physiological link between rRNA degradation and the inhibition of protein synthesis during apoptosis. For example, 28S rRNA is selectively degraded in Jurkat T cells and U937 cells by death receptor engagement (Nadano and Sato, 2000) . In another study, glucocorticoid calcium ionophore (A23187) and anisomycin, a potent protein synthesis inhibitor, induced 28S rRNA and DNA degradation (King et al., 2000) . The investigators concluded that the ribosome is a specific target for death effectors during apoptosis and that a caspase/Bcl2-independent pathway exists to activate its destruction. Our data suggests that eIF3f may associate with ribosome degradation, which may contribute to apoptosis in a caspase 3/Bcl2-independent pathway. However, further studies are required to elucidate the mechanism by which eIF3f causes ribosome degradation.
Presently, it is not completely clear how eIF3f is associated with rRNA degradation. It is possible that eIF3f may contain intrinsic nuclease activity. Alternatively, it is possible that eIF3f activates RNase L. RNase L is known to cleave rRNA during apoptosis (Xiang et al., 2003) . The 2-5A system is an established endogenous antiviral pathway. The 2-5A binds to and activates RNase L which leads to degradation of rRNA (Castelli et al., 1998) . RNase L activity is also suppressed by RNase-L-specific protein inhibitor (RLI) (Martinand et al., 1998) . The mechanism of inhibition of RNase L by RLI is not well defined; however, the ribosomal localization of RLI suggests that it could potentially protect rRNA from cleavage by RNase L (Dong et al., 2004) . In yeast, RLI co-purifies with eIF3 core subunits (specifically eIF3b) (Dong et al., 2004) . Depletion of RLI reduces the amount and size of polysomes in vivo. Whether eIF3f is associated with the 2-5A/RNase L pathway is still under investigation in our laboratory.
Materials and methods
Cell culture and tissue specimens A375, UACC647, UACC1227, UACC827 and UACC612 human melanoma cell lines, fibroblasts, normal melanocytes, BxPc3, MiaPaCa and Hs766T human pancreatic cancer cell lines and Jurkat T-cell line were obtained from American Type Culture Collection (ATCC, Manassas, VA, USA). The cells were cultured at 371C with 5% CO 2 in RPMI 1640 medium (Mediatech Inc., Herndon, VA, USA), supplemented with 10% fetal bovine serum (Omega Scientific Inc, Tarzana, CA, USA), 1% L-glutamine and 1% penicillin/streptomycin (Invitrogen, Carlsbad, CA, USA). All transfections were carried out using LipofectAMINE 2000 (Invitrogen) according to the manufacturer's instructions. Collection of melanoma and pancreatic cancer specimens was approved by the Human Subjects Committee of University of Arizona.
Construction of plasmids pGEX-eIF3f and four pGEX-eIF3f deletion constructs were constructed as previously described (Shi et al., 2003) . Figure 11 The 60S ribosomal subunit decreases during apoptosis in A375 melanoma cells. (a) A375 cells were treated with staurosporine (10 ng/ml) for 36 h followed by polysome profile analysis as described in Figure 9 . (b) The proteins in the fractions were analysed by 10% SDS/polyacrylamide gel electrophoresis and Western blot with eIF3f and eIF3b antibodies.
Aberrant expression of eIF3f in tumor cells J Shi et al pcDNA3-eIF3f was constructed by cloning full-length eIF3f into expression vector pcDNA3 (Invitrogen) using EcoRI and XhoI restriction sites. pCMV-HA-eIF3f was constructed by cloning full-length eIF3f into expression vector pCMV-HA (Clontech, Mountain View, CA, USA) using EcoRI and XhoI restriction sites.
Cancer profiling array A radioactive probe was generated using a human eIF3f cDNA fragment. The probe was labeled with [a-32 P]dCTP and hybridized against a cancer profiling array (BD; Clontech, Mountain View, CA, USA) according to the manufacturer's instructions. Ubiquitin probe provided by the manufacturer was used as control.
Quantitative real-time one step RT-PCR Total RNAs were extracted using the RNeasy Mini Kit (Qiagen, Valencia, CA, USA). Real-time RT-PCR was performed using SYBR s Green PCR Core Reagents (Applied Biosystems of PerkinElmer (ABI-PE), Foster City, CA, USA) and amplified in an ABI-PE prism 5700 sequence detection system as previously described (Shi et al., 2003) . All samples are amplified in triplicate to obtain means and s.d.s.
Colony assay
One thousand cells were seeded in 100-mm plates in triplicate and incubated for 2 weeks to allow colonies to form. Then the media were removed and colonies were stained with methylene blue solution (50% methanol and 0.5% methylene blue) at room temperature for 5 min. The plates were rinsed with water and colony number was counted.
Cell proliferation and apoptosis assay Cell proliferation was measured by the MTT assay as described (Ariza et al., 1999) . For apoptosis assay, cells were stained with 7-AAD and analysed for apoptosis using a FACStar flow cytometer (Becton Dickinson, San Jose, CA, USA) as described previously (Ariza et al., 1999) . Quantification of apoptotic index and cell viability was performed by using the fluorescent dyes acridine orange and ethidium bromide (100 mg/ml of each dye) and fluorescent microscopy (Mikolajczyk and Nelson, 2004) . A minimum of 200 cells were Aberrant expression of eIF3f in tumor cells J Shi et al
